Experimental Alzheimer's drug endorsed for full approval by FDA advisers Leqembi could become the first treatment of its kind to receive traditional approval from the FDA. Axios · Jun 9, 2023
New Alzheimer's drug faces uncertain regulatory path The FDA will soon decide whether to approve Eisai's experimental drug lecanemab. Axios · Nov 30, 2022